课题基金基金详情
应用核磁共振研究蛋白质机器p97转运底物蛋白的分子机制
结题报告
批准号:
31971144
项目类别:
面上项目
资助金额:
59.0 万元
负责人:
黄成栋
依托单位:
学科分类:
分子生物物理
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
黄成栋
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
作为哺乳细胞内丰度最高的枢纽蛋白之一,超大分子机器AAA ATPase p97参与调控蛋白降解、细胞膜融合、细胞生长周期等多个重要生命过程,并与包括癌症、阿兹海默以及帕金森等神经退行性疾病在内的众多人类疾病紧密相关。事实上,作为极有希望攻克上述疾病的药靶蛋白,关于p97的研究长久以来一直是国际上的研究热点之一。然而,由于p97与其底物分子的高度动态的内在结合特性使得相关研究颇为困难,严重阻碍了人们对于其功能机制的认知。本课题将以核磁共振为主要研究工具,对p97与底物蛋白的动态结合机理做深入系统的研究,阐明其相互作用机制,并力图解析出p97在底物转运过程的不同阶段与其底物分子的复合体结构,并据此从原子角度上阐明以ATP为燃料的p97底物分子转运机理。上述工作将帮助我们更好地理解p97蛋白在生命活动中的功能机制,并为药物设计提供重要的理论指导。
英文摘要
The essential and very abundant mammalian protein p97 (also called VCP or Cdc48 in yeast) is an AAA (ATPase associated with a variety of cellular activities) ATPase,which is involved in a variety of important cellular processes including protein degradation, homotypic membrane fusion and cell cycle control. Consequently, the central cellular hub p97 is closely linked to many human diseases, such as cancer and a number of neurodegenerative diseases including Alzheimer’s and Parkinson’s diseases. Indeed, p97 has been regarded as a very promising therapeutic target in the treatment of these diseases. However, mechanistic understanding of the function of this protein has been greatly hampered by the scarcity of knowledge that how p97 dynamically recognizes and interacts with its client proteins. By marring modern NMR methods with other biophysical and biochemical techniques, this project will focus primarily on the interaction studies of p97 with a few distinct client proteins,aiming to provide structural basis for the universal principles that govern the recognition and dynamic interaction of p97 with its clients. The ultimate goal of this project is to elucidate the mechanism that how the ATP-fueled motor p97 translocates its clients. We believe our efforts should provide a better mechanistic understanding of this critical protein, and thus eventually make significant contributions to.the area of therapeutic design.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1002/pro.4024
发表时间:2021-01-29
期刊:PROTEIN SCIENCE
影响因子:8
作者:Huang, Lin;Qu, Xiaozhan;Huang, Chengdong
通讯作者:Huang, Chengdong
DOI:10.1038/s41421-022-00424-z
发表时间:2022
期刊:Cell discovery
影响因子:--
作者:Hang Li;Tuo Ji;Qi Sun;Yao Chen;Weiya Xu;Chengdong Huang
通讯作者:Chengdong Huang
DOI:10.7554/elife.72535
发表时间:2021-12-13
期刊:eLife
影响因子:7.7
作者:Chen Y;Xu W;Yu S;Ni K;She G;Ye X;Xing Q;Zhao J;Huang C
通讯作者:Huang C
DOI:10.1038/s41467-023-42628-1
发表时间:2023-10-27
期刊:NATURE COMMUNICATIONS
影响因子:16.6
作者:Kong, Chao;Qu, Xiaozhan;Liu, Mingming;Xu, Weiya;Chen, Da;Zhang, Yanshen;Zhang, Shan;Zhu, Feng;Liu, Zhenbang;Li, Jianchao;Huang, Chengdong;Wang, Chao
通讯作者:Wang, Chao
超大动态分子伴侣蛋白Hsp90与其底物分子的作用机理研究
  • 批准号:
    31770807
  • 项目类别:
    面上项目
  • 资助金额:
    67.0万元
  • 批准年份:
    2017
  • 负责人:
    黄成栋
  • 依托单位:
国内基金
海外基金